A promising drug therapy for the treatment of sleep apnea, a serious and common sleep-related breathing disorder has been licensed by the University of Illinois at Chicago, where it was first conceptualized, to an intellectual property and technology commercialization company for clinical development.
A promising drug therapy for the treatment of sleep apnea, a serious and common sleep-related breathing disorder has been licensed by the University of Illinois at Chicago, where it was first conceptualized, to an intellectual property and technology commercialization company for clinical development.
http://www.sciencedaily.com/releases/2004/10/041005073612.htm
